These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27170400)

  • 1. Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma.
    Høgdall D; O'Rourke CJ; Taranta A; Oliveira DV; Andersen JB
    Dig Dis; 2016; 34(4):440-51. PubMed ID: 27170400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of intrahepatic cholangiocarcinoma.
    Andersen JB
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):101-13. PubMed ID: 25174625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
    Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
    Sirica AE; Gores GJ; Groopman JD; Selaru FM; Strazzabosco M; Wei Wang X; Zhu AX
    Hepatology; 2019 Apr; 69(4):1803-1815. PubMed ID: 30251463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma.
    Krasinskas AM
    Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cholangiocarcinoma.
    Mertens JC; Ilyas SI; Gores GJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1454-1460. PubMed ID: 28844952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
    Raggi C; Invernizzi P; Andersen JB
    J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma.
    Ko S; Kim M; Molina L; Sirica AE; Monga SP
    Adv Cancer Res; 2022; 156():283-317. PubMed ID: 35961703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
    Braconi C; Roessler S; Kruk B; Lammert F; Krawczyk M; Andersen JB
    Liver Int; 2019 May; 39 Suppl 1():32-42. PubMed ID: 30829432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.
    Xu AM; Xian ZH; Zhang SH; Chen XF
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of biliary carcinogenesis and growth.
    Wise C; Pilanthananond M; Perry BF; Alpini G; McNeal M; Glaser SS
    World J Gastroenterol; 2008 May; 14(19):2986-9. PubMed ID: 18494047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
    Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Hepatobiliary Cancers: The Oncology Way.
    Galle PR
    Dig Dis; 2017; 35(4):384-386. PubMed ID: 28468016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
    Dong L; Lu D; Chen R; Lin Y; Zhu H; Zhang Z; Cai S; Cui P; Song G; Rao D; Yi X; Wu Y; Song N; Liu F; Zou Y; Zhang S; Zhang X; Wang X; Qiu S; Zhou J; Wang S; Zhang X; Shi Y; Figeys D; Ding L; Wang P; Zhang B; Rodriguez H; Gao Q; Gao D; Zhou H; Fan J
    Cancer Cell; 2022 Jan; 40(1):70-87.e15. PubMed ID: 34971568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center.
    Jesper D; Heyn SG; Schellhaas B; Pfeifer L; Goertz RS; Zopf S; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2018 May; 30(5):552-556. PubMed ID: 29280922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.
    Sirica AE; Strazzabosco M; Cadamuro M
    Adv Cancer Res; 2021; 149():321-387. PubMed ID: 33579427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma.
    Kendre G; Murugesan K; Brummer T; Segatto O; Saborowski A; Vogel A
    J Hepatol; 2023 Mar; 78(3):614-626. PubMed ID: 36528236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.